Neuroprotective effect of CTE, an extract from traditional Chinese medicine, in a mouse model of MPTP-induced Parkinson's disease

Chinese Journal of New Drugs

Volumn 20, Issue 4, 2011, Pages 355-358

  Wu, Qian ^a,b   Ye, Min ^b   Pu, Xiao Ping ^a,b  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

HPLC EC; MPTP; Neuroprotection; Parkinson's disease; Traditional Chinese medicine extract

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CHINESE DRUG; CTE; DOPAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CHINESE MEDICINE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE;

EID: 80054038491     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. PEREIRA E A, AZIZ T Z. Parkinson's disease and primate research: past, present, and future [J]. Postgrad Med J, 2006, 82 (967): 293-299.
2. MEREDITH G E, TOTTERDELL S, POTASHKIN J A, et al. Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol[J]. Parkinsonism Relat Disord, 2008, 14 (Suppl 2):S112-S115.
3. LENAZ G, BARACCA A, FATO R, et al. Mitochondrial Complex I: structure, function, and implications in neurodegeneration [J]. Ital J Biochem, 2006, 55(3-4):232-253.
4. SCHAPIRA A H. Mitochondrial dysfunction in Parkinson's disease [J]. Cell Death Differ, 2007, 14(7):1261-1266.
5. 2008, 24(1):28-32.
6. 2007, 23(1):42-46.
7. 2006, 38 (6):92-93.
8. 2009, 28(6): 463-465.